Neonatal Antibiotic Treatment Is Associated With an Altered Circulating Immune Marker Profile at 1 Year of Age

Background: Neonatal antibiotics disturb the developing gut microbiome and are therefore thought to influence the developing immune system, but exact mechanisms and health consequences in later life still need to be elucidated. Therefore, we investigated whether neonatal antibiotics influence inflam...

Full description

Bibliographic Details
Main Authors: Berthe C. Oosterloo, Belinda van't Land, Wilco de Jager, Nicole B. Rutten, Margot Klöpping, Johan Garssen, Arine M. Vlieger, Ruurd M. van Elburg
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.02939/full
id doaj-abb5da3fd8494051a817e9d9a10c864e
record_format Article
spelling doaj-abb5da3fd8494051a817e9d9a10c864e2020-11-25T01:29:34ZengFrontiers Media S.A.Frontiers in Immunology1664-32242020-01-011010.3389/fimmu.2019.02939484087Neonatal Antibiotic Treatment Is Associated With an Altered Circulating Immune Marker Profile at 1 Year of AgeBerthe C. Oosterloo0Belinda van't Land1Belinda van't Land2Wilco de Jager3Nicole B. Rutten4Margot Klöpping5Johan Garssen6Johan Garssen7Arine M. Vlieger8Ruurd M. van Elburg9Department of Pediatrics, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, NetherlandsCenter for Translational Immunology, University Medical Centre Utrecht, Utrecht, NetherlandsDanone Nutricia Research, Utrecht, NetherlandsCenter for Translational Immunology, University Medical Centre Utrecht, Utrecht, NetherlandsSt. Antonius Hospital, Department of Pediatrics, Nieuwegein, NetherlandsCenter for Translational Immunology, University Medical Centre Utrecht, Utrecht, NetherlandsDanone Nutricia Research, Utrecht, NetherlandsUtrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, NetherlandsSt. Antonius Hospital, Department of Pediatrics, Nieuwegein, NetherlandsDepartment of Pediatrics, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, NetherlandsBackground: Neonatal antibiotics disturb the developing gut microbiome and are therefore thought to influence the developing immune system, but exact mechanisms and health consequences in later life still need to be elucidated. Therefore, we investigated whether neonatal antibiotics influence inflammatory markers at 1 year of age. In addition, we determined whether health problems during the first year of life, e.g., allergic disorders (eczema and wheezing) or infantile colics, were associated with changes in the circulating immune marker profile at 1 year of age.Methods: In a subgroup (N = 149) of the INCA-study, a prospective birth-cohort study, a blood sample was drawn from term born infants at 1 year of age and analyzed for 84 immune related markers using Luminex. Associations of antibiotic treatment, eczema, wheezing, and infantile colics with immune marker concentrations were investigated using a linear regression model. The trial is registered as NCT02536560.Results: The use of broad-spectrum antibiotics in the first week of life, was significantly associated with different levels of inflammatory markers including sVCAM-1, sCD14, sCD19, sCD27, IL-1RII, sVEGF-R1, and HSP70 at 1 year of age. Eczema was associated with decreased concentrations of IFNα, IFNγ, TSLP, CXCL9, and CXCL13, but increased concentrations of CCL18 and Galectin-3. Wheezing, independent of antibiotic treatment, was positively associated to TNF-R2 and resistin. Infantile colics were positively associated to IL-31, LIGHT, YKL-40, CXCL13, sPD1, IL1RI, sIL-7Ra, Gal-1, Gal-9, and S100A8 at 1 year of age, independent of early life antibiotic treatment.Conclusion: In this explorative study, we identified that neonatal antibiotics are associated with immunological alterations at 1 year of age and that, independent of the antibiotic treatment, infantile colics were associated with alterations within gut associated markers. These findings support the importance of the first host microbe interaction in early life immune development.https://www.frontiersin.org/article/10.3389/fimmu.2019.02939/fullbiomarkersimmune developmentinfantantibioticsinfantile coliceczema
collection DOAJ
language English
format Article
sources DOAJ
author Berthe C. Oosterloo
Belinda van't Land
Belinda van't Land
Wilco de Jager
Nicole B. Rutten
Margot Klöpping
Johan Garssen
Johan Garssen
Arine M. Vlieger
Ruurd M. van Elburg
spellingShingle Berthe C. Oosterloo
Belinda van't Land
Belinda van't Land
Wilco de Jager
Nicole B. Rutten
Margot Klöpping
Johan Garssen
Johan Garssen
Arine M. Vlieger
Ruurd M. van Elburg
Neonatal Antibiotic Treatment Is Associated With an Altered Circulating Immune Marker Profile at 1 Year of Age
Frontiers in Immunology
biomarkers
immune development
infant
antibiotics
infantile colic
eczema
author_facet Berthe C. Oosterloo
Belinda van't Land
Belinda van't Land
Wilco de Jager
Nicole B. Rutten
Margot Klöpping
Johan Garssen
Johan Garssen
Arine M. Vlieger
Ruurd M. van Elburg
author_sort Berthe C. Oosterloo
title Neonatal Antibiotic Treatment Is Associated With an Altered Circulating Immune Marker Profile at 1 Year of Age
title_short Neonatal Antibiotic Treatment Is Associated With an Altered Circulating Immune Marker Profile at 1 Year of Age
title_full Neonatal Antibiotic Treatment Is Associated With an Altered Circulating Immune Marker Profile at 1 Year of Age
title_fullStr Neonatal Antibiotic Treatment Is Associated With an Altered Circulating Immune Marker Profile at 1 Year of Age
title_full_unstemmed Neonatal Antibiotic Treatment Is Associated With an Altered Circulating Immune Marker Profile at 1 Year of Age
title_sort neonatal antibiotic treatment is associated with an altered circulating immune marker profile at 1 year of age
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2020-01-01
description Background: Neonatal antibiotics disturb the developing gut microbiome and are therefore thought to influence the developing immune system, but exact mechanisms and health consequences in later life still need to be elucidated. Therefore, we investigated whether neonatal antibiotics influence inflammatory markers at 1 year of age. In addition, we determined whether health problems during the first year of life, e.g., allergic disorders (eczema and wheezing) or infantile colics, were associated with changes in the circulating immune marker profile at 1 year of age.Methods: In a subgroup (N = 149) of the INCA-study, a prospective birth-cohort study, a blood sample was drawn from term born infants at 1 year of age and analyzed for 84 immune related markers using Luminex. Associations of antibiotic treatment, eczema, wheezing, and infantile colics with immune marker concentrations were investigated using a linear regression model. The trial is registered as NCT02536560.Results: The use of broad-spectrum antibiotics in the first week of life, was significantly associated with different levels of inflammatory markers including sVCAM-1, sCD14, sCD19, sCD27, IL-1RII, sVEGF-R1, and HSP70 at 1 year of age. Eczema was associated with decreased concentrations of IFNα, IFNγ, TSLP, CXCL9, and CXCL13, but increased concentrations of CCL18 and Galectin-3. Wheezing, independent of antibiotic treatment, was positively associated to TNF-R2 and resistin. Infantile colics were positively associated to IL-31, LIGHT, YKL-40, CXCL13, sPD1, IL1RI, sIL-7Ra, Gal-1, Gal-9, and S100A8 at 1 year of age, independent of early life antibiotic treatment.Conclusion: In this explorative study, we identified that neonatal antibiotics are associated with immunological alterations at 1 year of age and that, independent of the antibiotic treatment, infantile colics were associated with alterations within gut associated markers. These findings support the importance of the first host microbe interaction in early life immune development.
topic biomarkers
immune development
infant
antibiotics
infantile colic
eczema
url https://www.frontiersin.org/article/10.3389/fimmu.2019.02939/full
work_keys_str_mv AT berthecoosterloo neonatalantibiotictreatmentisassociatedwithanalteredcirculatingimmunemarkerprofileat1yearofage
AT belindavantland neonatalantibiotictreatmentisassociatedwithanalteredcirculatingimmunemarkerprofileat1yearofage
AT belindavantland neonatalantibiotictreatmentisassociatedwithanalteredcirculatingimmunemarkerprofileat1yearofage
AT wilcodejager neonatalantibiotictreatmentisassociatedwithanalteredcirculatingimmunemarkerprofileat1yearofage
AT nicolebrutten neonatalantibiotictreatmentisassociatedwithanalteredcirculatingimmunemarkerprofileat1yearofage
AT margotklopping neonatalantibiotictreatmentisassociatedwithanalteredcirculatingimmunemarkerprofileat1yearofage
AT johangarssen neonatalantibiotictreatmentisassociatedwithanalteredcirculatingimmunemarkerprofileat1yearofage
AT johangarssen neonatalantibiotictreatmentisassociatedwithanalteredcirculatingimmunemarkerprofileat1yearofage
AT arinemvlieger neonatalantibiotictreatmentisassociatedwithanalteredcirculatingimmunemarkerprofileat1yearofage
AT ruurdmvanelburg neonatalantibiotictreatmentisassociatedwithanalteredcirculatingimmunemarkerprofileat1yearofage
_version_ 1725096322225143808